| abstract |
Compounds that selectively inhibit the pathogenic production of human vascular endothelial growth factor (VEGF) and compositions comprising such compounds are described. Compounds that inhibit viral replication or production of viral RNA or DNA or viral proteins and compositions containing such compounds are described. Also described are methods of using the compounds to reduce VEGF, and methods for treating cancer and non-neoplastic conditions comprising administration of the compounds. Further described are methods of using the compounds to inhibit viral replication or production of viral RNA or DNA or viral proteins, and methods for treating viral infections comprising administration of the compounds. A compound can be administered to a human in need of such treatment as a single agent therapy or in combination with one or more additional therapies. [Selection figure] None |